AU2001231973A1 - Method for preparing functionalised beta-(1,3)-glucan derivatives - Google Patents

Method for preparing functionalised beta-(1,3)-glucan derivatives

Info

Publication number
AU2001231973A1
AU2001231973A1 AU2001231973A AU3197301A AU2001231973A1 AU 2001231973 A1 AU2001231973 A1 AU 2001231973A1 AU 2001231973 A AU2001231973 A AU 2001231973A AU 3197301 A AU3197301 A AU 3197301A AU 2001231973 A1 AU2001231973 A1 AU 2001231973A1
Authority
AU
Australia
Prior art keywords
beta
formula
glucan derivatives
preparing functionalised
functionalised
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001231973A
Other languages
English (en)
Inventor
Vincent Ferrieres
Frank Jamois
Daniel Plusquellec
Jean-Claude Yvin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Goemar SA
Original Assignee
Laboratoires Goemar SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Goemar SA filed Critical Laboratoires Goemar SA
Publication of AU2001231973A1 publication Critical patent/AU2001231973A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/08—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to sulfur, selenium or tellurium
    • C07H5/10—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to sulfur, selenium or tellurium to sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
AU2001231973A 2000-02-04 2001-02-02 Method for preparing functionalised beta-(1,3)-glucan derivatives Abandoned AU2001231973A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0001429A FR2804684B1 (fr) 2000-02-04 2000-02-04 Procede pour la preparation de derives fonctionnalises de beta-(1,3)-glucanes
FR0001429 2000-02-04
PCT/FR2001/000329 WO2001057053A1 (fr) 2000-02-04 2001-02-02 PROCEDE POUR LA PREPARATION DE DERIVES FONCTIONNALISES DE β-(1,3)-GLUCANES

Publications (1)

Publication Number Publication Date
AU2001231973A1 true AU2001231973A1 (en) 2001-08-14

Family

ID=8846670

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001231973A Abandoned AU2001231973A1 (en) 2000-02-04 2001-02-02 Method for preparing functionalised beta-(1,3)-glucan derivatives

Country Status (11)

Country Link
US (1) US6951934B2 (fr)
EP (1) EP1252171B1 (fr)
JP (1) JP2003523331A (fr)
AT (1) ATE370155T1 (fr)
AU (1) AU2001231973A1 (fr)
CA (1) CA2399161C (fr)
DE (1) DE60129929T2 (fr)
ES (1) ES2292557T3 (fr)
FR (1) FR2804684B1 (fr)
PT (1) PT1252171E (fr)
WO (1) WO2001057053A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050065114A1 (en) * 2003-09-23 2005-03-24 Jean-Claude Yvin Therapeutical treatment with oligo-beta- (1,3) -glucans, drugs used in said treatment
US7070778B2 (en) 2003-10-30 2006-07-04 Laboratoire Goemar Sa Therapeutical combination against cancer
FR2910322B1 (fr) * 2006-12-22 2009-10-30 Mer Soc Par Actions Simplifiee Utilisation d'oligo-b-(1,3)-glucanes modifies pour le traite traitement de maladies du systeme immunitaire, oligo-b-(1,3) glucane-(1,3)-mannose, oligo-b-(1,3)-glucane-(1,3)-mannitol et leurs derives, ...
US20100076239A1 (en) * 2007-09-07 2010-03-25 University Of South Florida Asymmetric cyclopropanation of electron-deficient olefins with diazo reagents
EP2920193A4 (fr) * 2012-11-16 2016-09-14 Univ Arizona State Synthèse de tensioactifs à base de glucide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR860379B (en) * 1985-02-22 1986-06-11 Akzo Nv Novel disaccharide and trisaccharide derivatives of the lipid a type
US5721368A (en) * 1996-07-22 1998-02-24 Merck & Co. Inc. Process for synthesizing carbapenem side chain intermediates
FR2777281B1 (fr) * 1998-04-14 2000-06-30 Goemar Lab Sa Procede de synthese du d-laminaribiose

Also Published As

Publication number Publication date
ES2292557T3 (es) 2008-03-16
WO2001057053A1 (fr) 2001-08-09
DE60129929T2 (de) 2008-04-30
EP1252171B1 (fr) 2007-08-15
ATE370155T1 (de) 2007-09-15
CA2399161A1 (fr) 2001-08-09
US6951934B2 (en) 2005-10-04
JP2003523331A (ja) 2003-08-05
FR2804684B1 (fr) 2002-06-28
DE60129929D1 (de) 2007-09-27
US20030045706A1 (en) 2003-03-06
PT1252171E (pt) 2007-11-15
FR2804684A1 (fr) 2001-08-10
EP1252171A1 (fr) 2002-10-30
CA2399161C (fr) 2010-10-12

Similar Documents

Publication Publication Date Title
CY1106015T1 (el) Ενα συμπυκνωμενο, υδατοδιαλυτο, κοκκωδες σκευασμα ρυθμιστη της φυτικης αναπτυξης και μεθοδοι χρησης και ιδιου
NZ301695A (en) use of aerogels which has been surface modified by silylation as carrier materials in agricultural and veterinary compositions
GEP20063917B (en) Pulmonary administration of chemically modified insulin
WO2005007197A3 (fr) Molecules biologiques conjuguees et leur preparation
GEP20002180B (en) Composition and Methods for Stimulating Megakaryocyte Growth and Differentiation
DE50014571D1 (de) Träger-pharmaka-konjugate
BG102100A (en) Method for the preparation of monomer con-conjugates of kalicheamycin derivative/carrier
FI19992070A (fi) Uudet fukosyloidut oligosakkaridit ja menetelmä niiden valmistamiseksi
WO2002101412A3 (fr) Compositions lyophilisees de pulverisation
AU2770097A (en) Polymer powders redispersible in aqueous solution
BR0115605A (pt) Derivados de naftaleno
TW200637499A (en) Composition composed of highly dispersible cellulose complex and polysaccharide
BR0014939A (pt) Oligossacarìdeos, processo de preparação de oligossacarìdeos, composições farmacêuticas, e, utilização de oligossacarìdeos
EP1493754A4 (fr) Polysaccharide contenant un groupe phosphorylcholine et procede de production correspondant
SE9600716L (sv) Adhesionsinhibitorer, preparat innehållande desamma och förfarande för framställning därav
AU8471191A (en) New heterocycle-substituted alkylamines, process for preparing these and pharmaceutical compositions containing them
HUP0102515A2 (hu) Ciklopeptidek, eljárás előállításukra, hatóanyagként azokat tartalmazó gyógyszerkészítmények és alkalmazásuk
ATE305942T1 (de) Dextranderivate, verfahren zu deren herstellung und verwendungen als arzneimittel mit spezifischer, biologischer wirkung
AU2001231973A1 (en) Method for preparing functionalised beta-(1,3)-glucan derivatives
DK0722477T3 (da) Vandige polymerisatfremstillinger
AU4621500A (en) Novel aluminosiloxane compound and process for preparing the same
AU4050699A (en) Solid water-soluble or water-dispersible compositions
MXPA04005788A (es) Proceso para preparacion de derivados de [1,4,5]-oxadiazepina.
EP1132383A4 (fr) Nouveaux derives d'aloefurane, leur procede de preparation, les preparations pharmaceutiques les contenant et leur utilisation comme medicament
NZ510116A (en) Tricyclic delta-3-piperidines as pharmaceuticals